ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICARDO SANTAYANA MD

Internal Medicine

21,042

$680K

602
519 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $56

SYED HASAN M.D.

Internal Medicine

21,033

$822K

872
571 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

CRISTIAN BRETON M.D.

Internal Medicine

21,031

$1.1M

716
613 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

IVAN DELRIO MD

Internal Medicine

21,024

$666K

569
541 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $56

MAHMUD AHMED M.D.

Internal Medicine

21,021

$729K

1090
781 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $56

MARTHA RODRIGUEZ M.D.

Internal Medicine

20,968

$791K

1069
965 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $56

NIDIA CHEDIAK M.D.

Internal Medicine

20,941

$649K

975
870 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $56

FRANCISCO MACHADO M.D.

Internal Medicine

20,907

$837K

931
731 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $56

CHARANJIT AHLUWALIA MD

Internal Medicine

20,882

$1.17M

540
418 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

MICHAEL MORRISON M.D

Internal Medicine

20,865

$618K

883
732 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $56

JOSE STABLE MD

Internal Medicine

20,839

$695K

767
702 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

GEORGE HERDEL M.D.

Internal Medicine

20,793

$957K

1144
953 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $56

JUAN DELGADO M.D.

Internal Medicine

20,789

$549K

536
503 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$26
Average prescription price

Avg: $56

RICHARD CUELLO FUENTES M.D.

Internal Medicine

20,786

$1.14M

701
614 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

MOHAMMAD YAMANI M.D.

Internal Medicine

20,763

$705K

1235
925 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

JAY BERGER MD

Internal Medicine

20,709

$1.11M

663
508 are 65+

25%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

ASDRUBAL SEPULVEDA MD

Internal Medicine

20,704

$714K

867
631 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

CHARLES STONE MD

Internal Medicine

20,687

$1.1M

785
711 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $56

MANUEL OJEDA MD

Internal Medicine

20,682

$1.4M

520
445 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

MANUEL GARCIA-HERRAN MD

Internal Medicine

20,642

$1.37M

1249
1101 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

JOSE ALLONGO M.D.

Internal Medicine

20,576

$588K

841
783 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$29
Average prescription price

Avg: $56

MICHAEL COLLIER MD

Internal Medicine

20,511

$1.3M

1175
1051 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

VINAY SRIVASTAVA M.D.

Internal Medicine

20,511

$921K

695
525 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

JAYANT GAJERA M.D.

Internal Medicine

20,443

$916K

419
346 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

MILTON BENGOA M. D

Internal Medicine

20,378

$1.26M

655
490 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank